The Full Wiki

More info on Ezlopitant

Ezlopitant: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
CAS number 147116-64-1
ATC code none
PubChem 188927
ChemSpider 164166
Chemical data
Formula C31H38N2O 
Mol. mass 454.65 g/mol
Pharmacokinetic data
Excretion Urine (32%), Feces (51%)
Therapeutic considerations
Pregnancy cat.  ?
Legal status Uncontrolled
Routes Oral

Ezlopitant (CJ-11,974) is an NK1 receptor antagonist.[1][2][3] It has antiemetic and antinociceptive effects.[4][5] Pfizer was developing ezlopitant for the treatment of irritable bowel syndrome but it appears to have been discontinued.[1]

See also


  1. ^ a b Evangelista S (October 2001). "Eziopitant. Pfizer". Current Opinion in Investigational Drugs (London, England : 2000) 2 (10): 1441–3. PMID 11890362. 
  2. ^ Diemunsch P, Grélot L (September 2000). "Potential of substance P antagonists as antiemetics". Drugs 60 (3): 533–46. PMID 11030465. 
  3. ^ Giardina GA, Gagliardi S, Martinelli M (August 2003). "Antagonists at the neurokinin receptors--recent patent literature". IDrugs : the Investigational Drugs Journal 6 (8): 758–72. PMID 12917772. 
  4. ^ Tsuchiya M, Fujiwara Y, Kanai Y, et al. (November 2002). "Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret". Pharmacology 66 (3): 144–52. PMID 12372904. 
  5. ^ Tsuchiya M, Sakakibara A, Yamamoto M (January 2005). "A tachykinin NK1 receptor antagonist attenuates the 4 beta-phorbol-12-myristate-13-acetate-induced nociceptive behaviour in the rat". European Journal of Pharmacology 507 (1-3): 29–34. doi:10.1016/j.ejphar.2004.11.028. PMID 15659291. 


Got something to say? Make a comment.
Your name
Your email address